|
CRDL Cardiol Therapeutics Inc 1702123 |
| Income Statement |
|
Net Income
|
2023-12-31
|
$-28,128,292.00 |
| Balance Sheet |
|
Current Assets
|
$36,153,092.00 |
|
Assets
|
$36,700,508.00 |
|
Current Liabilities
|
$8,295,469.00 |
|
Liabilities
|
$8,454,001.00 |
|
Equity
|
$28,246,507.00 |
|
Shares Out
|
65352279.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-25,180,441.00 |
|
Investing Cash Flow
|
$-64,312.00 |
| Market Analysis |
Market Cap
|
$79,076,257.59 |
|
Price
|
$1.23 |
|
BVPS
|
0.43 |
|
PB
|
2.81 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRDL documents filed with the SEC.
CRDL Filings
Clear
